Clinical Trials Sponsored by Pharmaceutical Research Network

Total 2607 results

Allegheny Singer Research Institute (also known...

Terminated

Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer

Breast Cancer | Radiotherapy Side Effect | Radiation Dermatitis | Radiotherapy; Complications | Radiotherapy; Adverse Effect, Dermatitis or Eczema | Radiation Burn

United States
Allegheny Singer Research Institute (also known...

Recruiting

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

Breast Cancer | Breast Cancer Female | Breast Carcinoma in Situ

United States
Allegheny Singer Research Institute (also known...

Recruiting

EXERT-BCN: An Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer (EXERT-BCN)

Breast Cancer

United States
Allegheny Singer Research Institute (also known...

Active, not recruiting

A Study to Evaluate Routine Chest Tube Management After Minimally Invasive Lung Surgery

Lung Cancer

United States
Allegheny Singer Research Institute (also known...

Active, not recruiting

Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease

Epithelial Ovarian Cancer

United States
Allegheny Singer Research Institute (also known...

Terminated

Immediate Weight-bearing Verses Non-Weight-bearing After Foot & Ankle Surgery

Foot and Ankle Surgery

United States
Allegheny Singer Research Institute (also known...

Completed

Deep Brain Stimulation Effects on Weight Change and Metabolic Rate

Obesity

United States
Allegheny Singer Research Institute (also known...

Completed

Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH

Pulmonary Arterial Hypertension

United States
NPO International TRI Network
Duke Clinical Research Institute; European Cardiovascular Research Center

Unknown

Radial Artery Patency and Bleeding, Efficacy, Adverse evenT Trial (RAPandBEAT)

Percutaneous Coronary Intervention
Xi'an Xintong Pharmaceutical Research Co.,Ltd.

Recruiting

Safety, Tolerability Phase Ia Study of XT1061 in Single and Multiple Doses in Healthy Subjects (XT1061)

Chronic Hepatitis b

China
Beker Laboratories
Pharmaceutical Research Unit, Jordan

Completed

Evaluation of the Efficacy and Safety of the Fixed-dose Combination Sofosdac® 400mg/60mg in Patients With Chronic Hepatitis C (HCV)

Chronic Hepatitis c

Algeria
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Unknown

A Phase I Study of AC0010 in Patients With CLL/ SLL, MCL, DLBCL and Other NHL

B-cell Lymphoma

China
Baylor Research Institute
Ultragenyx Pharmaceutical Inc

Completed

Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body Disease

Adult Polyglucosan Body Disease | Glycogen Brancher Enzyme Deficiency | Glycogen Storage Disease Type IV

France
Hangzhou ACEA Pharmaceutical Research Co., Ltd.

Completed

Study to Investigate the Absorption, Metabolism and Excretion of [14C] AC0010 in Patients With Advanced NSCLC

Carcinoma, Non-Small-Cell Lung

China
Johnson & Johnson Pharmaceutical Research & Development...

Approved for marketing

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Urogenital Neoplasms | Genital Neoplasms, Male | Prostate Neoplasms | Genital Diseases, Male

United States, Australia, Hong Kong, Spain, Colombia, Mexico, Poland, Malaysia, Romania, Canada, Greece, Taiwan, Korea, Republic of, New Zealand, Singapore, Brazil, Russian Federation, Czech Republic, Puerto Rico, Thailand, Hungary and more
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy and Safety Study of Prucalopride in Participants With Chronic Constipation (Resolor)

Constipation

China, Taiwan, Australia, Korea, Republic of, Thailand
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Effect of Food on Levofloxacin Pharmacokinetics From an Oral Solution Formulation

Healthy
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy Subjects

Healthy
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone

Arrhythmias, Cardiac
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge Model

Asthma

Germany, United Kingdom
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins

Red-Cell Aplasia, Pure
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression

Major Depressive Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Effect of Food on the Pharmacokinetics of a Single JNJ-39823277 (TPI-1062) Dose in Healthy Participants

Healthy

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia

Schizophrenia

United States, Ukraine, Germany, Spain, India, Russian Federation, Czech Republic, Austria, Hungary, Lithuania, Bulgaria, Estonia, Poland, France
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia

Schizophrenia

United States, Ukraine, Taiwan, Malaysia, Romania, Russian Federation, Serbia, Korea, Republic of
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers

Gastroesophageal Reflux

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers

Healthy

Belgium
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma

Asthma

United States, India, Canada, Romania
Johnson & Johnson Pharmaceutical Research & Development...

Terminated

An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot

Tinea Pedis

Poland, United Kingdom
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of, United States, Germany
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection

Musculoskeletal Diseases

United States, Costa Rica, Argentina, Brazil, Chile, Israel, Mexico, Panama
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer

Breast Cancer

United States, Poland, Ukraine, United Kingdom, Spain, Israel, Bulgaria, Romania, Serbia, South Africa, Russian Federation, Hungary, Lithuania, Netherlands, Latvia, Portugal, Estonia, France
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Ketamine Challenge Study With JNJ-40411813

Confusion | Schizophrenia | Perceptual Disorders

Germany
Johnson & Johnson Pharmaceutical Research & Development...

Completed

JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) Study

Healthy

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic and Drug Interaction Study of JNJ-26489112 in Healthy Volunteers

Healthy

Belgium
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy and Safety Study of 3 Fixed Doses of JNJ-37822681 in Participants With Schizophrenia

Schizophrenia

Taiwan, Malaysia, Romania, South Africa, Ukraine, Korea, Republic of, Russian Federation, Bulgaria, Lithuania, Estonia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia

Schizophrenia

Belgium, Germany, Russian Federation, Slovakia, Sweden
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Safety Study of Mebendazole in Children 2 to 10 Years of Age

Healthy Volunteers

Tanzania
Johnson & Johnson Pharmaceutical Research & Development...

Completed

An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain

Pain

China
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate of the Absorption, Metabolism, and Excretion of 14C-JNJ-39823277 in Healthy Male Participants

Healthy

Belgium
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pivotal Study to Evaluate the Bio-equivalence of the Tapentadol Extended-Release (ER) Tamper-resistant Formulation (TRF) Tablet to the Current Tapentadol ER Prolonged-release 2 (PR2) Tablet

Healthy

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of JNJ-404118413 in Healthy Male Patients

Healthy

Germany
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Single and Multiple Dose Study to Explore the Safety Of JNJ-40346527 In Healthy Volunteers

Health

Belgium
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes

Bipolar Disorder

United States, Ukraine, Taiwan, Spain, Poland, India, Malaysia, Russian Federation, Slovakia, Austria
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure

Heart Failure

Belgium, Germany, Poland, Romania
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Phase 1 Pharmacokinetic Study of Tapentadol Prolonged-Release 250 Milligram (mg) Formulation in Healthy Participants

Healthy

Netherlands
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Observe the Causes and Treatment of Anemia in Critically Ill Children

Anemia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Simvastatin in Healthy Volunteers

Healthy

Clinical Trials Sponsored by Pharmaceutical Research Network

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations